newsfilter
← Latest News
PR Newswire·

Viking Therapeutics Announces Proposed Offerings of Common Stock and Convertible Senior Notes

Viking Therapeutics, Inc. (Nasdaq: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and...